Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

People with Down syndrome are more likely to have alopecia areata and need regular skin check-ups.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Post-exposure syndromes are persistent conditions caused by past exposures, needing unique interventions.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Blocking androgens at birth reduces sexual motivation in male rats.

Dr. Rasmussen disagrees with Alexander and Schor, emphasizing uncertainty in genital wart transmission and advocating for discussions on potential abuse and referrals in such cases.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.

The boy's symptoms suggest a possible new medical condition.

Hirsutism and acne indicate high androgen levels in women with PCOS, and early treatment can improve symptoms and quality of life.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

The most common PCOS type in adolescents is hyperandrogenic with polycystic ovaries.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

Anabolic-androgenic steroids harm male hormone levels, sperm, metabolism, and can cause acne, hair loss, and breast growth.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

GABAergic steroid precursors reduce ethanol withdrawal symptoms in certain mice.

Metabolic syndrome worsens treatment outcomes for urinary symptoms in men with enlarged prostate.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

Post-Exposure Syndromes are persistent conditions caused by past exposures, needing unique interventions.

Many North African women with acne also have PCOS, showing more severe symptoms and higher testosterone levels.

A young woman's rare ovarian tumor was successfully removed, improving her hormonal symptoms.

People with PCOS often have skin problems like excessive hair growth, hair loss, acne, and dark patches, which are linked to hormonal and metabolic imbalances.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Most women with hyperandrogenism first show acne, and skin conditions like hirsutism and acanthosis nigricans are good indicators of the condition.

Mutations in the NR3C1 gene cause a rare condition that affects hormone signaling and can lead to various symptoms, with dexamethasone as a treatment option.